| 1. |
- Curceanu, C., et al.
(författare)
-
Kaonic deuterium measurement with Siddharta-2 on daΦNE
- 2020
-
Ingår i: Acta Physica Polonica B. - 0587-4254. ; 51:1, s. 251-257
-
Tidskriftsartikel (refereegranskat)abstract
- The interaction of antikaons with nucleons and nuclei in the low-energy regime represents an active research field in hadron physics with still many important open questions. The investigation of light kaonic atoms is, in this context, a unique tool to obtain precise information on this interaction. The most precise kaonic hydrogen measurement to date, together with an exploratory measurement of kaonic deuterium, were carried out by the SIDDHARTA Collaboration at the DAΦNE electron–positron collider of LNF-INFN, by combining the excellent quality kaon beam delivered by the collider with new experimental techniques, as fast and precise Silicon-Drift X-ray detectors. The measurement of kaonic deuterium will be realized in the near future by SIDDHARTA-2, a major upgrade of SIDDHARTA.
|
|
| 2. |
- Miliucci, M., et al.
(författare)
-
Kaonic Deuterium Precision Measurement at DA Φ NE : The SIDDHARTA-2 Experiment
- 2020
-
Ingår i: Recent Progress in Few-Body Physics : Proceedings of the 22nd International Conference on Few-Body Problems in Physics, FB22 2018 - Proceedings of the 22nd International Conference on Few-Body Problems in Physics, FB22 2018. - Cham : Springer International Publishing. - 0930-8989 .- 1867-4941. - 9783030323561 - 9783030323578 ; 238, s. 965-969
-
Bokkapitel (refereegranskat)abstract
- Light kaonic atoms spectroscopy offers the unique opportunity to perform experiments equivalent to scattering at vanishing relative energies. This allows the determination of the antikaon-nucleus interaction at threshold, without the need of extrapolation to zero energy, as in the case of scattering experiments. In this framework, the SIDDHARTA-2 collaboration aims to perform the first measurement of kaonic deuterium transition to the fundamental level, which is mandatory to extract the isospin dependent antikaon—nucleon scattering lengths. The experiment will be carried out at the DA(formula presented)NE collider of LNF-INFN in 2019–2020.
|
|
| 3. |
|
|
| 4. |
|
|
| 5. |
- Chioncel, Ovidiu, et al.
(författare)
-
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of Cardiology
- 2020
-
Ingår i: European Journal of Heart Failure. - : WILEY. - 1388-9842 .- 1879-0844. ; 22:8, s. 1315-1341
-
Tidskriftsartikel (refereegranskat)abstract
- Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high mortality, developing as a continuum, and progressing from the initial insult (underlying cause) to the subsequent occurrence of organ failure and death. There is a large spectrum of CS presentations resulting from the interaction between an acute cardiac insult and a patients underlying cardiac and overall medical condition. Phenotyping patients with CS may have clinical impact on management because classification would support initiation of appropriate therapies. CS management should consider appropriate organization of the health care services, and therapies must be given to the appropriately selected patients, in a timely manner, whilst avoiding iatrogenic harm. Although several consensus-driven algorithms have been proposed, CS management remains challenging and substantial investments in research and development have not yielded proof of efficacy and safety for most of the therapies tested, and outcome in this condition remains poor. Future studies should consider the identification of the new pathophysiological targets, and high-quality translational research should facilitate incorporation of more targeted interventions in clinical research protocols, aimed to improve individual patient outcomes. Designing outcome clinical trials in CS remains particularly challenging in this critical and very costly scenario in cardiology, but information from these trials is imperiously needed to better inform the guidelines and clinical practice. The goal of this review is to summarize the current knowledge concerning the definition, epidemiology, underlying causes, pathophysiology and management of CS based on important lessons from clinical trials and registries, with a focus on improving in-hospital management.
|
|
| 6. |
|
|
